🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Autoimmune › Massachusetts › Boston

Qorannoo klinikaalii Dhibee Autoimmune Boston, MA keessatti

Qorannoo 13 Dhibee Autoimmune f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Namoota walitti qabaa jiraSadarkaa 1
  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

Namoota walitti qabaa jiraSadarkaa 3
  • Tufts Medical Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07621809

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Namoota walitti qabaa jiraSadarkaa 3
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06722235

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Namoota walitti qabaa jiraSadarkaa 2/3
  • Boston Children's Hospital - Accepting Young Adults and Juvenile Patients, Boston
Umuriin 6 hanga 75 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06154252

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Namoota walitti qabaa jiraSadarkaa 3
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06948318

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Namoota walitti qabaa jiraSadarkaa 1/2
  • Tufts Medical Center, Boston
  • Massachusetts General Hospital, Boston
  • Boston Children's Hospital, Boston
  • fi 1 dabalataa
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06121297

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Namoota walitti qabaa jiraSadarkaa 1/2
  • Beth Israel Deaconess Medical Center, Boston
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT06359041

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

Namoota walitti qabaa jiraSadarkaa 3
  • Boston Children's Cancer Center, Boston
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06056297

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Namoota walitti qabaa jiraSadarkaa 1
  • Brigham And Womens Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT07115745

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Tufts Medical Center, Boston
  • Beth Israel Deaconess, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

Namoota walitti qabaa jiraSadarkaa 1
  • Tufts University, Boston
  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 30-Wax-2026 · NCT06201416

Testimonials and Navigation in Rheumatology

Namoota walitti qabaa jira
  • Brigham Women's Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT06469788

Qorannoo Dhibee Autoimmune magaalota biroo keessatti

Qorannoo biroo Boston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.